BridgeBio Pharma (BBIO) Gross Profit (QoQ) (2020 - 2026)
BridgeBio Pharma (BBIO) Gross Profit (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.36% |
| Dec 31, 2025 | 27.98% |
| Sep 30, 2025 | 6.76% |
| Jun 30, 2025 | -6.21% |
| Mar 31, 2025 | 2,901.42% |
| Dec 31, 2024 | 77.98% |
| Sep 30, 2024 | 35.92% |
| Jun 30, 2024 | -99.25% |
| Mar 31, 2024 | 18,254.14% |
| Dec 31, 2023 | -67.16% |
| Sep 30, 2023 | 235.22% |
| Jun 30, 2023 | -11.32% |
| Mar 31, 2023 | -3.92% |
| Dec 31, 2022 | 404.99% |
| Sep 30, 2022 | -100.55% |
| Jun 30, 2022 | 21,011.56% |
| Mar 31, 2022 | -95.90% |
| Dec 31, 2021 | 849.33% |
| Sep 30, 2021 | -98.35% |
| Dec 31, 2020 | -98.50% |